Please login to the form below

Not currently logged in
Email:
Password:

Fred Powell joins Celator as chief financial officer

Joins oncology specialist from OraPharma

Fred Powell, Celator Celator has hired Fred Powell as chief financial officer.

He joins from OraPharma, and will be responsible for the oncology specialist's accounting, corporate finance, financial planning, investor relations and administration functions.

"Fred brings a tremendous skill set and experience base to a company at our stage, with a 20-year track record in the biopharmaceutical industry that includes private and public financings, mergers and acquisitions, and domestic and global operations,” said Scott Jackson, CEO of Celator Pharmaceuticals.

“He will make an immediate and substantive contribution to our success."

During his time at OraPharma, Powell helped the company through several transitions, helping to establish it as a stand-alone business after its sale by Johnson & Johnson in late 2010, and then supporting its acquisition by Valeant Pharmaceuticals in June, 2012.

Prior to joining OraPharma, he was the chief financial officer of BMP Sunstone Corporation, a US specialty pharmaceutical, overseeing its eventual sale to Sanofi.

Powell also held senior finance and administration positions at Eximias Pharmaceutical Corporation, Innaphase Corporation, and ERT (formerly EResearch Technology).

20th December 2012

From: Sales

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
SEVEN STONES

Seven Stones is a creative, independent healthcare communications agency of movers and thinkers. We've been doing health differently since 1991....

Latest intelligence

Patient engagement
Taking a holistic approach to patient care
The importance of recognising each patient as an individual...
The concordance conundrum – the tech divide
“Hello? Can you hear me? I think you are on mute” – how many times have we all heard this over the past five or so months? Not exactly the...
3 ways to increase patient retention rates in clinical trials
Retention rates are falling in clinical trials. Yes, it is a bit disheartening. But there are some straightforward things you can do to turn it around....

Infographics